<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299414</url>
  </required_header>
  <id_info>
    <org_study_id>1U01HL119242-01</org_study_id>
    <secondary_id>U01HL119242-01</secondary_id>
    <nct_id>NCT02299414</nct_id>
  </id_info>
  <brief_title>Chronic Hypertension and Pregnancy (CHAP) Project</brief_title>
  <acronym>CHAP</acronym>
  <official_title>A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Drexel University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lehigh Valley Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Peters University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ochsner Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>WakeMed Health and Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Francisco General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McKay-Dee Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York Hospital Queens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Latter Day Saints Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lyndon B Johnson General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virtua Medical Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayview Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Utah Valley Regional Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwestern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brown (WIHRI)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Case Western/Metro Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unity Point Health-Meriter Hospital WI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beaumont Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Denver Health and Hospital Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gundersen Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aurora Health Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New Jersey Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether a blood pressure treatment strategy during
      pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults
      (&lt;140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP
      is severe) is effective and safe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During pregnancy, chronic hypertension (CHTN) is the most common major medical disorder
      encountered, occurring in 2-6%. The substantial negative effect of CHTN on pregnancy includes
      a consistent 3- to 5-fold increase in superimposed preeclampsia and adverse perinatal
      outcomes (fetal or neonatal death, preterm birth -PTB, poor fetal growth and placental
      abruption) and possibly a 5- to10-fold increase in maternal cardiovascular and other
      complications (death, cerebrovascular accident, pulmonary edema and acute renal failure).
      Mild CHTN (BP &lt;160/110) contributes to a large proportion of these adverse outcomes. While
      antihypertensive treatment of CHTN is standard for the general population, it is uncertain
      whether treatment during pregnancy reduces maternal or fetal complications, and there are
      concerns that decreased arterial pressure may reduce fetal blood flow and cause poor fetal
      growth or small-for-gestational-age (SGA) infants. Some authorities, including the American
      College of Obstetricians and Gynecologists (ACOG) and American Society of Hypertension (ASH)
      recommend withholding antihypertensive therapy for mild CHTN, particularly if BP is
      &lt;160/105-110 mmHg. The recommendation to withhold antihypertensive treatment in pregnancy
      conflicts with the broader public health goal to reduce BP in those with CHTN and there is no
      evidence that discontinuing therapy during the brief period of pregnancy affects maternal
      outcomes (other than reducing the severe hypertension). For over a decade, authorities have
      consistently called for well-designed and powered trials to delineate the benefits and risks
      of pharmacologic therapy for CHTN during pregnancy.

      Therefore, our multicenter consortium proposes the Chronic Hypertension and Pregnancy (CHAP)
      Project, a large pragmatic randomized trial with a primary aim to evaluate the benefits and
      harms of pharmacologic treatment of mild CHTN in pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite adverse perinatal outcome</measure>
    <time_frame>Up to 2 weeks after delivery</time_frame>
    <description>One of more severe outcomes including fetal or neonatal death up to 2 weeks; preeclampsia with severe features (Severe hypertension and proteinuria or hypertension and severe features per ACOG); placental abruption; or indicated PTB &lt;35 weeks (not due to spontaneous preterm labor or membrane rupture).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Small for Gestational Age</measure>
    <time_frame>Until delivery</time_frame>
    <description>Birth weight less than 10th percentile for gestational age at birth according to accepted national standard</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of maternal death or severe cardiovascular morbidity</measure>
    <time_frame>Up to 6 weeks (4-12 weeks) after delivery</time_frame>
    <description>One or more of maternal death, heart failure, stroke, encephalopathy, Myocardial infarction or ischemia, pulmonary edema, ICU admission, or renal failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of severe adverse perinatal outcome</measure>
    <time_frame>Up to 6 weeks (4-12 weeks) after delivery</time_frame>
    <description>One or more of perinatal death, IVH III or IV, BPD or chronic lung disease, NEC, ROP, Seizures, Proven sepsis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to treatment after delivery</measure>
    <time_frame>Up to 6 weeks (4-12 weeks) after delivery</time_frame>
    <description>Adherence to antihypertensive therapy after delivery</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Preeclampsia</measure>
    <time_frame>Up to 2 weeks after delivery</time_frame>
    <description>Mild or severe, including eclampsia</description>
  </other_outcome>
  <other_outcome>
    <measure>Superimposed gestational hypertension</measure>
    <time_frame>Enrollment (between 6 and 18 weeks gestation) to delivery</time_frame>
    <description>Persistent hypertension above baseline without proteinuria occurring after 20 weeks gestation</description>
  </other_outcome>
  <other_outcome>
    <measure>Severe hypertension</measure>
    <time_frame>Up to 6 weeks (4-12 weeks) after delivery</time_frame>
    <description>Blood pressure ≥160/110</description>
  </other_outcome>
  <other_outcome>
    <measure>Cesarean delivery</measure>
    <time_frame>Until delivery</time_frame>
    <description>Cesarean delivery</description>
  </other_outcome>
  <other_outcome>
    <measure>Preterm birth</measure>
    <time_frame>At birth</time_frame>
    <description>Delivery at &lt;37 weeks</description>
  </other_outcome>
  <other_outcome>
    <measure>NICU admission</measure>
    <time_frame>Up to 6 weeks (4-12 weeks) after delivery</time_frame>
    <description>NICU admission and length of NICU stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Low birth weight</measure>
    <time_frame>At birth</time_frame>
    <description>Birth weight &lt;2500g</description>
  </other_outcome>
  <other_outcome>
    <measure>Ponderal index</measure>
    <time_frame>At birth</time_frame>
    <description>Mean ponderal index</description>
  </other_outcome>
  <other_outcome>
    <measure>Head circumference</measure>
    <time_frame>At birth</time_frame>
    <description>Mean head circumference</description>
  </other_outcome>
  <other_outcome>
    <measure>Placental weight</measure>
    <time_frame>At delivery</time_frame>
    <description>Mean placental weight</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypoglycemia</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Prevalence of hypoglycemia</description>
  </other_outcome>
  <other_outcome>
    <measure>Bradycardia</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Prevalence of bradycardia</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypotension</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with hypotension</description>
  </other_outcome>
  <other_outcome>
    <measure>Respiratory distress syndrome (RDS)</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with RDS</description>
  </other_outcome>
  <other_outcome>
    <measure>Bronchopulmonary dysplasia (BPD)</measure>
    <time_frame>Up to 3 months after delivery</time_frame>
    <description>Incidence (%) with BPD</description>
  </other_outcome>
  <other_outcome>
    <measure>Intubation/ventilation</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with intubation for ventilation</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraventricular hemorrhage (IVH)</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with any IVH and with IVH Grades III and IV</description>
  </other_outcome>
  <other_outcome>
    <measure>Necrotizing enterocolitis (NEC)</measure>
    <time_frame>Up to 3 months after delivery</time_frame>
    <description>Incidence (%) with NEC</description>
  </other_outcome>
  <other_outcome>
    <measure>Hyperbilirubinemia</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with hyperbilirubinemia</description>
  </other_outcome>
  <other_outcome>
    <measure>5-min Apgar score</measure>
    <time_frame>At delivery</time_frame>
    <description>Apgar score &lt;7</description>
  </other_outcome>
  <other_outcome>
    <measure>Sepsis</measure>
    <time_frame>From delivery to hospital discharge (2 - 3 days after delivery)</time_frame>
    <description>Incidence (%) with sepsis</description>
  </other_outcome>
  <other_outcome>
    <measure>Unscheduled prenatal clinic or ER visits</measure>
    <time_frame>Up to 3 months after delivery</time_frame>
    <description>Number of unscheduled clinic or ER visits before and after delivery</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalizations</measure>
    <time_frame>Up to 3 months postpartum</time_frame>
    <description>Number of hospitalizations before or after delivery</description>
  </other_outcome>
  <other_outcome>
    <measure>Postpartum unscheduled or ER visits</measure>
    <time_frame>Up to 3 months after delivery</time_frame>
    <description>Number of postpartum unscheduled or ER visits</description>
  </other_outcome>
  <other_outcome>
    <measure>Postpartum hospitalizations</measure>
    <time_frame>Up to 3 months after delivery</time_frame>
    <description>Number of postpartum hospitalizations</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4700</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Anti-hypertensive therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Labetalol or Nifedipine ER will be used as first-line to achieve target BP &lt;140/90; if necessary Nifedipine ER or Labetalol will be second-line antihypertensive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No anti-hypertensive therapy (or low dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antihypertensive therapy given only if BP becomes severe (defined as BP ≥160/105). The lowest dose of anti-hypertensive needed to keep blood pressure below this threshold will be given (1st-line - Labetalol or Nifedipine ER and 2nd-line - Labetalol or Nifedipine ER).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-hypertensive therapy</intervention_name>
    <description>1st line anti-hypertensive (Labetalol or Nifedipine ER) started; escalate to maximum dose and a preferred 2nd line medication if needed (nifedipine ER or Labetalol)</description>
    <arm_group_label>Anti-hypertensive therapy</arm_group_label>
    <other_name>Normodyne</other_name>
    <other_name>Trandate</other_name>
    <other_name>Procardia XL</other_name>
    <other_name>Adalat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No anti-hypertensive therapy (unless BP is severe)</intervention_name>
    <description>Treatment will not be started if blood pressure remains &lt;160/105; for blood pressure ≥160/105, treatment with labetalol or Nifedipine ER will be initiated and maintained at lowest dose needed to keep blood pressure under 160/105.</description>
    <arm_group_label>No anti-hypertensive therapy (or low dose)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women with chronic hypertension in pregnancy with new or untreated chronic
             hypertension, blood pressure 140-159 systolic or 90-104 diastolic OR known chronic
             hypertension on monotherapy and taking any antihypertensive and blood pressure
             ≤159/104 (including those with blood pressure &lt;140/90);

          2. Singleton; and

          3. viable pregnancy &lt;23 weeks of gestation.

        Exclusion Criteria:

          1. Blood pressures prior to randomization ≥160 systolic or ≥105 diastolic (with or
             without treatment);

          2. Patients currently treated with &gt;1 antihypertensive medication (more likely to have
             severe chronic hypertension);

          3. Multi-fetal pregnancy;

          4. Known secondary cause of chronic hypertension;

          5. High-risk co-morbidities for which treatment may be indicated:

               -  Class C or higher diabetes mellitus

               -  Chronic kidney disease - including baseline proteinuria (&gt;300mg/24-hr, p/c ratio
                  &gt;0.3, or persistent 1+ proteinuria*) or creatinine &gt;1.2.

                  *If a dipstick value at screening is more than trace, a clean catch or catheter
                  urine should be obtained and re-tested by dipstick. If this shows trace or
                  absence of protein, the patient is included. If it again shows 1+ protein, the
                  patient is excluded until a 24-hr urine &lt;300mg/24hr or p/c ratio is &lt;0.3.

               -  Cardiac disorders: cardiomyopathy, angina, CAD

               -  Prior stroke

               -  Retinopathy

               -  Sickle cell disease;

          6. Known major fetal anomaly;

          7. Known fetal demise;

          8. Suspected IUGR;

          9. Membrane rupture or planned termination prior to randomization;

         10. Plan to deliver outside the consortium centers (unless approved by the Clinical
             Coordinating Center) or unlikely to follow-up in the opinion of study staff or
             previous participation in this trial;

         11. Contraindication to labetalol or nifedipine (e.g. know hypersensitivity); and (12)
             Current substance abuse or addiction (cocaine, methamphetamine) *The minimum age
             varies by center
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Tita, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham - Clinical Coordinating Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gary Cutter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham-Data Coordinating Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alan Tita, MD, PhD</last_name>
    <phone>205-934-5612</phone>
    <email>atita@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michelle Feese, MPH</last_name>
    <phone>205-975-8633</phone>
    <email>mfeese@uab.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham, Clinical Coordinating Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan T Tita, MD, PhD</last_name>
      <email>atita@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Alan Tita, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alabama at Birmingham, Data Coordinating Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>General Hospital of San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Norton, MD</last_name>
      <email>nortonm@obgyn.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Norton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Norton, MD</last_name>
      <phone>415-353-7865</phone>
      <email>nortonm@obgyn.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Norton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasser El-Sayed, MD</last_name>
      <phone>650-723-3198</phone>
      <email>elsayed@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Yasser El-Sayed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torri Metz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Torri Metz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Denver Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torri Metz, MD</last_name>
      <email>Torri.Metz@dhha.org</email>
    </contact>
    <investigator>
      <last_name>Torri Metz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Hoffman, MD, MPH</last_name>
    </contact>
    <investigator>
      <last_name>Matthew Hoffman, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Derman, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Odibo</last_name>
      <email>lodibo@health.usf.edu</email>
    </contact>
    <investigator>
      <last_name>Judette Louis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David M Haas, MD</last_name>
      <email>dahaas@iu.edu</email>
    </contact>
    <investigator>
      <last_name>David M Haas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Lawrence</city>
        <state>Kansas</state>
        <zip>66045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Parrish, DO</last_name>
      <email>mparrish@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Parrish, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Health System/Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherri Longo, MD</last_name>
      <phone>504-842-4151</phone>
      <email>slongo@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Sherri Longo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dotun Ogunyemi, MD</last_name>
      <email>dogunye@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Dotun Ogunyemi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ray Bahado-Singh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical College</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Owens, MD</last_name>
      <email>myowens@umc.edu</email>
    </contact>
    <investigator>
      <last_name>Michelle Owens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George A Macones, MD, MSCE</last_name>
      <phone>314-362-7139</phone>
      <email>Maconesg@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>George Macones, MD, MSCE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Methodius Tuuli, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Rosen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Todd Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Peters University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janelle Faroutan, MD</last_name>
      <email>jforoutan@saintpetersuh.com</email>
    </contact>
    <investigator>
      <last_name>Kristy Palomares, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janelle Faroutan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Rosen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Todd Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virtua Medical Group</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Librizzi, DO</last_name>
      <email>RLibrizzi@Virtua.ORG</email>
    </contact>
    <investigator>
      <last_name>Ronald Librizzi, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Queens</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Skupski, MD</last_name>
      <email>dwskupsk@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Skupski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Kinzler, MD</last_name>
      <email>wkinzler@winthrop.org</email>
    </contact>
    <investigator>
      <last_name>Wendy Kinzler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Cleary, MD</last_name>
      <phone>212-305-1527</phone>
      <email>klc2108@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Kirsten Cleary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ron Wapner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phyllis August, MD, MPH</last_name>
      <email>paugust@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Boggess, MD</last_name>
      <phone>919-966-1601</phone>
      <email>Kim.boggess@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Kim Boggess, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke Regional Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Murtha, MD</last_name>
      <email>amy.murtha@dm.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Murtha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brenna Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geeta Swamy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Murtha, MD</last_name>
      <email>amy.murtha@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Murtha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geeta Swamy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brenna Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WakeMed</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Bogess, MD</last_name>
      <email>KBoggess@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Kim Boggess, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Case Western/Metro Health</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Gibson, MD</last_name>
      <email>kgibson@metrohealth.org</email>
    </contact>
    <investigator>
      <last_name>Edward Chien, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly Gibson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalin Buhimschi, MD</last_name>
      <email>Catalin.Buhimschi@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Catalin Buhimschi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney Edwards, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge E. Tolosa, MD, MSCE</last_name>
      <email>tolosaj@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Tolosa, MD, MSCE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonardo Pereira, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital/Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Drexel University College of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Plante, MD, MPH</last_name>
    </contact>
    <investigator>
      <last_name>Lauren Plante, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Dugoff, MD</last_name>
      <email>Lorraine.Dugoff@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Lorraine Dugoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Dugoff, MD</last_name>
      <email>Lorraine.Dugoff@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Lorraine Dugoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Dugoff, MD</last_name>
      <phone>215-615-3739</phone>
      <email>Lorraine.Dugoff@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Lorraine Dugoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Goetzl, MD, MPH</last_name>
    </contact>
    <investigator>
      <last_name>Laura Goetzl, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburg/Magee Women's Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyagriv Simhan, MD, MS</last_name>
      <phone>412-641-4874</phone>
      <email>hsimhan@mail.magee.edu</email>
    </contact>
    <investigator>
      <last_name>Hyagriv Simhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brown (WIHRI)</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julio Fernando Mateus Nino, MD</last_name>
      <email>mateusan@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Julio Fernando Mateus Nino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UT Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George R Saade, MD</last_name>
      <phone>409-747-0482</phone>
      <email>gsaade@utmb.edu</email>
    </contact>
    <investigator>
      <last_name>George Saade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyndon B. Johnson Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kjersti Aagard, MD</last_name>
      <email>aagaardt@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Kjersti Aagard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector Mendez-Figueroa, MD</last_name>
      <phone>713-500-7780</phone>
      <email>Hector.R.MendezFigueroa@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Sean Blackwell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Baha Sibai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hector Mendez-Figueroa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McKay Dee Hospital</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Varner, MD</last_name>
      <email>Michael.varner@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Varner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Intermountain Healthcare</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Varner, MD</last_name>
      <email>Michael.Varner@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Varner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Varner, MD</last_name>
      <email>Michael.Varner@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Varner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LDS Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Varner, MD</last_name>
      <email>Michael.varner@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Varner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gundersen Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Schauberger, MD</last_name>
      <email>cwschaub@gundersenhealth.org</email>
    </contact>
    <investigator>
      <last_name>Charles Schauberger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unity Point Health-Meriter Hospital</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinesh M Shah, MD</last_name>
      <email>dmshah@wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Dinesh M Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kara Hoppe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazumasa Hashimoto, MD</last_name>
      <email>'Hashimotokazumasa@marshfieldclinic.org</email>
    </contact>
    <investigator>
      <last_name>Kazumasa Hashimoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Palatnik, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anna Palatnik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Research Institute</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Stone, MD</last_name>
      <email>'ryan.stone@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Ryan Stone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Alan Tita</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Chronic hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
    <mesh_term>Labetalol</mesh_term>
    <mesh_term>Nifedipine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

